These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22402442)

  • 1. A UVR-induced G2-phase checkpoint response to ssDNA gaps produced by replication fork bypass of unrepaired lesions is defective in melanoma.
    Wigan M; Pinder A; Giles N; Pavey S; Burgess A; Wong S; Sturm RA; Gabrielli B
    J Invest Dermatol; 2012 Jun; 132(6):1681-8. PubMed ID: 22402442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gap-filling and bypass at the replication fork are both active mechanisms for tolerance of low-dose ultraviolet-induced DNA damage in the human genome.
    Quinet A; Vessoni AT; Rocha CR; Gottifredi V; Biard D; Sarasin A; Menck CF; Stary A
    DNA Repair (Amst); 2014 Feb; 14():27-38. PubMed ID: 24380689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATR- and ATM-Mediated DNA Damage Response Is Dependent on Excision Repair Assembly during G1 but Not in S Phase of Cell Cycle.
    Ray A; Blevins C; Wani G; Wani AA
    PLoS One; 2016; 11(7):e0159344. PubMed ID: 27442013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XRCC4 in G1 suppresses homologous recombination in S/G2, in G1 checkpoint-defective cells.
    Saintigny Y; Delacôte F; Boucher D; Averbeck D; Lopez BS
    Oncogene; 2007 Apr; 26(19):2769-80. PubMed ID: 17057732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma.
    Pavey S; Spoerri L; Haass NK; Gabrielli B
    Pigment Cell Melanoma Res; 2013 Nov; 26(6):805-16. PubMed ID: 23837768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple interaction nodes define the postreplication repair response to UV-induced DNA damage that is defective in melanomas and correlated with UV signature mutation load.
    Pavey S; Pinder A; Fernando W; D'Arcy N; Matigian N; Skalamera D; Lê Cao KA; Loo-Oey D; Hill MM; Stark M; Kimlin M; Burgess A; Cloonan N; Sturm RA; Gabrielli B
    Mol Oncol; 2020 Jan; 14(1):22-41. PubMed ID: 31733171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cdk-mediated phosphorylation of Chk1 is required for efficient activation and full checkpoint proficiency in response to DNA damage.
    Xu N; Libertini S; Black EJ; Lao Y; Hegarat N; Walker M; Gillespie DA
    Oncogene; 2012 Mar; 31(9):1086-94. PubMed ID: 21765472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A majority of human melanoma cell lines exhibits an S phase-specific defect in excision of UV-induced DNA photoproducts.
    Bélanger F; Rajotte V; Drobetsky EA
    PLoS One; 2014; 9(1):e85294. PubMed ID: 24416382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-ssDNA.
    Zhang H; Head PE; Daddacha W; Park SH; Li X; Pan Y; Madden MZ; Duong DM; Xie M; Yu B; Warren MD; Liu EA; Dhere VR; Li C; Pradilla I; Torres MA; Wang Y; Dynan WS; Doetsch PW; Deng X; Seyfried NT; Gius D; Yu DS
    Cell Rep; 2016 Feb; 14(6):1435-1447. PubMed ID: 26854234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression.
    Kaufmann WK; Nevis KR; Qu P; Ibrahim JG; Zhou T; Zhou Y; Simpson DA; Helms-Deaton J; Cordeiro-Stone M; Moore DT; Thomas NE; Hao H; Liu Z; Shields JM; Scott GA; Sharpless NE
    J Invest Dermatol; 2008 Jan; 128(1):175-87. PubMed ID: 17597816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAD6-RAD18-RAD5-pathway-dependent tolerance to chronic low-dose ultraviolet light.
    Hishida T; Kubota Y; Carr AM; Iwasaki H
    Nature; 2009 Jan; 457(7229):612-5. PubMed ID: 19079240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase.
    Müllers E; Silva Cascales H; Jaiswal H; Saurin AT; Lindqvist A
    Cell Cycle; 2014; 13(17):2733-43. PubMed ID: 25486360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of S-phase progression triggered by UVA-induced ROS does not require a functional DNA damage checkpoint response in mammalian cells.
    Girard PM; Pozzebon M; Delacôte F; Douki T; Smirnova V; Sage E
    DNA Repair (Amst); 2008 Sep; 7(9):1500-16. PubMed ID: 18603484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Srs2 plays a critical role in reversible G2 arrest upon chronic and low doses of UV irradiation via two distinct homologous recombination-dependent mechanisms in postreplication repair-deficient cells.
    Hishida T; Hirade Y; Haruta N; Kubota Y; Iwasaki H
    Mol Cell Biol; 2010 Oct; 30(20):4840-50. PubMed ID: 20713444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intrinsic S/G
    Saldivar JC; Hamperl S; Bocek MJ; Chung M; Bass TE; Cisneros-Soberanis F; Samejima K; Xie L; Paulson JR; Earnshaw WC; Cortez D; Meyer T; Cimprich KA
    Science; 2018 Aug; 361(6404):806-810. PubMed ID: 30139873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for functional DNA polymerase eta in genome-wide repair of UV-induced DNA damage during S phase.
    Auclair Y; Rouget R; Belisle JM; Costantino S; Drobetsky EA
    DNA Repair (Amst); 2010 Jul; 9(7):754-64. PubMed ID: 20457011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the G2/M transition by p53.
    Taylor WR; Stark GR
    Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the S and G2 checkpoint to treat cancer.
    Chen T; Stephens PA; Middleton FK; Curtin NJ
    Drug Discov Today; 2012 Mar; 17(5-6):194-202. PubMed ID: 22192883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.